Ebert W - Search Results

1

Comparison of changes in the NSE levels with clinical assessment in the therapy monitoring of patients with SCLC.

Ebert W, Muley T, Trainer C, Dienemann H, Drings P. Ebert W, et al. Anticancer Res. 2002 Mar-Apr;22(2B):1083-9. Anticancer Res. 2002. PMID: 12168905

2

Increased CYFRA 21-1 and CEA levels are negative predictors of outcome in p-stage I NSCLC.

Muley T, Dienemann H, Ebert W. Muley T, et al. Among authors: ebert w. Anticancer Res. 2003 Sep-Oct;23(5b):4085-93. Anticancer Res. 2003. PMID: 14666606

3

CYFRA 21-1 and CEA are independent prognostic factors in 153 operated stage I NSCLC patients.

Muley T, Dienemann H, Ebert W. Muley T, et al. Among authors: ebert w. Anticancer Res. 2004 May-Jun;24(3b):1953-6. Anticancer Res. 2004. PMID: 15274383 Free article.

4

Does the assessment of serum markers in patients with lung cancer aid in the clinical decision making process?

Ebert W, Muley T, Drings P. Ebert W, et al. Anticancer Res. 1996 Jul-Aug;16(4B):2161-8. Anticancer Res. 1996. PMID: 8694537 Review.

5

Monitoring of therapy in inoperable lung cancer patients by measurement of CYFRA 21-1, TPA- TP CEA, and NSE.

Ebert W, Hoppe M, Muley T, Drings P. Ebert W, et al. Anticancer Res. 1997 Jul-Aug;17(4B):2875-8. Anticancer Res. 1997. PMID: 9329552

6

CYFRA 21-1 in the follow-up of inoperable non-small cell lung cancer patients treated with chemotherapy.

Ebert W, Muley T. Ebert W, et al. Anticancer Res. 1999 Jul-Aug;19(4A):2669-72. Anticancer Res. 1999. PMID: 10470217

7

Technical performance and diagnostic utility of the new Elecsys neuron-specific enolase enzyme immunoassay.

Muley T, Ebert W, Stieber P, Raith H, Holdenrieder S, Nagel D, Fürst H, Roth HJ, Luthe H, Blijenberg BG, Gurr E, Uhl W, von Pawel J, Drings P. Muley T, et al. Among authors: ebert w. Clin Chem Lab Med. 2003 Jan;41(1):95-103. doi: 10.1515/CCLM.2003.017. Clin Chem Lab Med. 2003. PMID: 12636057

8

Tumor volume and tumor marker index based on CYFRA 21-1 and CEA are strong prognostic factors in operated early stage NSCLC.

Muley T, Fetz TH, Dienemann H, Hoffmann H, Herth FJ, Meister M, Ebert W. Muley T, et al. Among authors: ebert w. Lung Cancer. 2008 Jun;60(3):408-15. doi: 10.1016/j.lungcan.2007.10.026. Epub 2008 Feb 20. Lung Cancer. 2008. PMID: 18083270

9

Prognostic value of increased lung tumor tissue cathepsin B.

Ebert W, Knoch H, Werle B, Trefz G, Muley T, Spiess E. Ebert W, et al. Anticancer Res. 1994 May-Jun;14(3A):895-9. Anticancer Res. 1994. PMID: 8074490

10

Do neuron-specific enolase levels discriminate between small-cell lung cancer and mediastinal tumors?

Ebert W, Ryll R, Muley T, Hug G, Drings P. Ebert W, et al. Tumour Biol. 1996;17(6):362-8. doi: 10.1159/000218001. Tumour Biol. 1996. PMID: 8938952

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

165 results

Search Page

Filters